Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry
CardioVascular and Interventional Radiology · 2024
DOI: 10.1007/s00270-023-03608-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2024. Verfasst von Ganesh Vigneswaran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, University Hospital Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Embolization, Therapeutic, Diabetes Mellitus, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Prostate artery embolisation (PAE) is a key treatment for the management of symptomatic benign prostatic hyperplasia (BPH). Common cardiovascular risk factors might be associated with suboptimal outcomes and thus influence patient treatment selection. The aim of the study was to evaluate whether cardiovascular comorbidities affect PAE outcomes.
Methods
Retrospective subset analysis of the UK Registry of Prostate Artery Embolisation (UK-ROPE) database was performed with patients who had a full documented past medical histories including hypertension, diabetes, coronary artery disease (CAD), diabetes and smoking status as well as international prostate symptom score (IPSS) at baseline and at 12 months. Multiple regression was performed to assess for any significant predictors.
Results
Comorbidity data were available for 100/216 patients (mean age 65.8 ± 6.4 years), baseline IPSS 20.9 ± 7.0). Regression analysis revealed that the presence of hypertension (53.7% IPSS reduction vs. absence 51.4%, p = 0.94), diabetes (52.6% vs. absence 52.1%, p = 0.6), CAD (59.2% vs. absence 51.4%, p = 0.95), no comorbidities (49.8% vs. any comorbidity present 55.3%, p = 0.66), smoking status (non-smoker, 52.6%, current smoker, 61.5%, ex-smoker, 49.8%, p > 0.05), age ( p = 0.52) and baseline Qmax ( p = 0.41) did not significantly impact IPSS reduction at 12 months post-PAE. Baseline prostate volume significantly influenced IPSS reduction (≥ 80 cc prostates, 58.9% vs. < 80 cc prostates 43.2%, p < 0.05).
Conclusion
The presence of cardiovascular comorbidities/smoking history does not appear to significantly impact PAE symptom score outcomes at 12 months post procedure. Our findings suggest that if the prostatic artery can be accessed, then clinical success is comparable to those without cardiovascular comorbidities. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Radiology, University Hospital Southampton, Southampton, UK.
- Cancer Sciences, University of Southampton, Southampton, UK.
- Department of Urology, University Hospital Southampton, Southampton, UK.
- Department of Interventional Radiology, University Hospital Southampton, Southampton, UK. sachin.modi@uhs.nhs.uk.
Zitieren
APA
Vigneswaran, G., Maclean, D., Doshi, N., Harris, M., Bryant, T. J. C., Hacking, N. C., Somani, B., & Modi, S. (2024). Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-023-03608-6
Vancouver
Vigneswaran G, Maclean D, Doshi N, Harris M, Bryant TJC, Hacking NC, et al. Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry. CardioVascular and Interventional Radiology. 2024. doi:10.1007/s00270-023-03608-6
BibTeX
@article{Vigneswaran2024,
author = {Vigneswaran, Ganesh and Maclean, Drew and Doshi, Neel and Harris, Mark and Bryant, Timothy J C and Hacking, Nigel C and Somani, Bhaskar and Modi, Sachin},
title = {Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry},
journal = {CardioVascular and Interventional Radiology},
year = {2024},
doi = {10.1007/s00270-023-03608-6}
}
EUVIMED